Concord, N.H.'s GO Bonds Rated 'AA';Ratings Affirmed Jan 99

  • ID: 2039759
  • January 1999
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's CreditWire) Jan. 28, 1999 -– Standard & Poor's today assigned its double-'A' rating to Concord, N.H.'s GO bonds due Oct. 1, 2018. The bonds are scheduled to sell Feb. 3, 1999. At the same time, Standard & Poor's affirmed its double-'A' rating on the city's outstanding GO bonds series 1991, 1995, and 1997. The bonds are secured by an unlimited ad valorem tax pledge. The rating on Concord reflects: --ýA solid economic base, --ýA strong financial position, and --ýA moderate debt burden. These factors are offset by average wealth and income levels and uncertainty surrounding the still unresolved statewide school funding issue. Concord is located in southern New Hampshire about 70 miles north of Boston....

Companies mentioned in this report are:
- Concord

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.